Cadila Pharmaceuticals

Cadila Pharma has shown decades of long leadership in combating infectious diseases, driven by a commitment to science, innovation, and accessibility. We are committed to delivering next-generation anti-infective therapies that protect lives, advance global healthcare, and preserve antibiotic effectiveness for future generations by providing high-quality, reliable treatment options and supporting rational antimicrobial use.

#

Bacterial infections remain a significant cause of morbidity and mortality worldwide. The urgency of this situation is heightened by the alarming rise of Antimicrobial Resistance (AMR), a major global health threat that complicates the management of common conditions. Globally, AMR was linked to an estimated 4.95 million deaths in 2019, with 1.27 million deaths directly attributed to antibiotic resistance.

India also faces a particularly significant infectious disease burden, and the country is the largest consumer of antibiotics globally in terms of absolute volume. The government currently has the highest Drug Resistance Index (DRI), indicating the lowest level of antibiotic effectiveness among all analysed countries.

Busy hospital outpatient reception area with patients seated in the waiting lounge

Portfolio highlights: Advanced 
anti-infective therapies

Cadila Pharma offers a specialised portfolio of anti-infective agents, utilising advanced technological formulations to enhance efficacy and patient outcomes in the fight against resistant pathogens.

Tambac is a Cefpodoxime formulation engineered for superior performance.

Smiling young woman giving thumbs up as a doctor checks her heartbeat with a stethoscope
Rapid relief with smarter absorption

Symbiotik XL delivers the widely used combination of Amoxicillin and Clavulanic Acid, ensuring reliable efficacy against common bacterial infections.

Doctor checking a young girl with a stethoscope as her smiling mother looks on
Stable, reliable infection defence

Ferowall is a crucial therapeutic option in the management of complicated and resistant infections.

Senior Indian man lovingly caring for his smiling wife at home, representing healthy ageing
Advanced defence for resistant infections

Brand names are for reference purpose only and shall not be treated as an advertisement. Please consult a registered medical practitioner before taking any medication.

downWhiteCurveArrow

Corporate Identification No : U24231GJ1991PLC015132

©2026 Cadila Pharmaceuticals. All rights reserved